Z-1685-2016 Class II Terminated

Recalled by Diamedix Corporation — Miami Lakes, FL

FDA device recall Z-1685-2016 was initiated by Diamedix Corporation on Oct 20, 2014 and is designated Class II. Reason for recall: A gel-like substance was found in kit component, sample diluent , that could potentially compromise product performance. The recall status is terminated (terminated Dec 14, 2016). Affected quantity: 697 kits.

Recall details

Product Type
Devices
Report Date
May 25, 2016
Initiation Date
Oct 20, 2014
Termination Date
Dec 14, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
697 kits

Product description

Diamedix Is-Mumps IgG Test Kit Diamedix Is-Mumps IgG Test Kit is an EIA procedure intended for the qualitative and semi-quantitative detection of Mumps IgG antibodies as an aid in the diagnosis of Mumps infection.

Reason for recall

A gel-like substance was found in kit component, sample diluent , that could potentially compromise product performance.

Distribution pattern

Worldwide distribution: US nationwide including states of: AZ, CA, CO, FL, GA, IL, IN, KY, MA, MI, MO, NC, NE, NH, NJ, NY, OH, OK, OR, PA, RI, TN, TX, VA, WI and Puerto Rico. and Country of: ITALY.

Code information

Lot # 20804, Catalog # 720-540. Expiration Date August 31, 2015

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1685-2016
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Diamedix Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-1685-2016. Report a data issue: hello@regdatalab.com.